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resistance (Bach et al., 2013). We recently showed
that inflammatory cytokines acutely stimulate glucose metabolism despite their antagonistic effects on insulin signaling (Cadaret et al.,
2017b). However, we hypothesize that chronic
exposure alters responsiveness to cytokines and
results in basal cytokine concentrations having
a greater inhibitory tone. Furthermore, chronic
maternal inflammation may induce fetal inflammatory adaptations that impair muscle growth
and metabolism. Therefore, our objective was to
determine the effects of sustained maternal inflammation on fetal growth, islet function, and
muscle glucose metabolism.

INTRODUCTION
Intrauterine growth restriction (IUGR) is
linked to metabolic dysfunction in offspring,
but the mediating mechanisms are still under investigation (Barker et al., 1993). IUGR fetuses
adapt to their poor intrauterine environment by
repartitioning nutrients to organs critical for
survival (i.e., brain, heart) at the expense of tissues such as muscle (Yates et al., 2012c). These
developmental adaptations help the fetus to
survive in utero but have lifelong consequences
in offspring; persistent reduction of highly
metabolic muscle mass is detrimental to glucose
homeostasis (DeFronzo et al., 1981). Glucose
metabolism is regulated primarily by insulin,
and nutrient depravation is associated with
impaired β-cell mass, insulin secretion, and insulin action in the IUGR fetus (Limesand et al.,
2006). Moreover, inflammation disrupts insulin
action and aids in the development of insulin

MATERIALS AND METHODS
Animals and Experimental Design
Experiments were approved by the Institutional
Animal Care and Use Committee at the University
of Nebraska-Lincoln, which is accredited by
AAALAC International. Timed-mated Polypay ewes
were administered saline (control, n = 9) or 0.1 µg/
kg BW (i.v.) of bacterial lipopolysaccharide (LPS;
n = 7; E. coli O55:B5; Sigma-Aldrich) every third
day from 100 to 115 d of gestation (dGA) to produce
maternal inflammation-induced IUGR (MI-IUGR)
fetuses. At 118 ± 2 dGA, indwelling catheters and
a perivascular flow probe were surgically placed in
fetal femoral arteries and veins and exteriorized at
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the ewe’s flank as previously described (Limesand
et al., 2007). Maternal and fetal blood samples were
taken at 123 dGA and complete blood counts (CBC,
HemaTrue Veterinary Chemistry Analyzer, Heska)
were performed for total and differential white blood
cell (WBC) analysis. Glucose-stimulated insulin secretion (GSIS) and hyperinsulinemic-euglycemic clamp
(HEC) studies were performed at 123 and 124 dGA,
respectively, and ewes were euthanized at 125 ± 2
dGA. At necropsy, fetal soleus muscles were isolated
for ex vivo metabolic studies.

Fetal GSIS Studies
To determine β-cell function, a square-wave
hyperglycemic clamp was performed at 123 ± 2 dGA
in control (n = 6) and MI-IUGR fetuses (n = 5) as previously described (Yates et al., 2012b). Three baseline
fetal blood samples were collected in 5-min intervals,
and an intravenous fetal glucose bolus (3,000 mM;
1 mL/kg fetal BW) was then administered followed
by continuous variable-rate glucose infusion in order
to target steady-state glucose concentrations of
~2.5 mM. After 30 min of steady-state hyperglycemia,
three fetal blood samples were collected at 5-min
intervals. Blood collected in EDTA syringes was centrifuged (14,000 × g, 2 min, 4 °C) to isolate plasma to
determine insulin concentrations via ELISA (Ovine
Insulin; Alpco). Blood collected in heparin-coated
syringes underwent blood gas, glucose, and lactate
analysis using an ABL90 Flex (Radiometer).
Fetal HEC Studies
Hindlimb glucose utilization and oxidation rates
were evaluated in control (n = 4) and MI-IUGR
(n = 4) fetuses at baseline and during HEC at 124 ± 2
dGA. Fetal lambs were bolused (1 mL, i.v.) with
U-[14C]-glucose tracer (18.75 µCi/mL; Perkin-Elmer)
followed by infusion at a constant rate (2 mL/kg/h).
After 40 min, venous and arterial blood samples were
collected simultaneously in heparin-coated syringes
at 5-min intervals (four total draws). Fetuses were
bolused with glucose (3,000 mM, 2 mL/kg BW) and
insulin (500 mU/mL; 0.5 mL/kg BW; Humulin-R,
Eli Lilly) followed by infusion (glucose, variable; insulin, 0.5 mL/kg/h). After HEC was achieved for 2 h,
venous and arterial blood samples were collected
simultaneously in 5-min intervals (four total draws)
as described above. Additional venous and arterial
blood was collected at each time point to measure
glucose oxidation. Blood containing glucose tracer
was added to micro-centrifuge tubes containing 2 M
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HCl suspended inside sealed 20-mL scintillation vial
with 1 M NaOH at the bottom. HCl releases CO2
from blood, which is then recaptured by the NaOH
in the scintillation vial. After 24-h incubation at
room temperature, the centrifuge tube was removed
and UltimaGold scintillation fluid (Perkin-Elmer)
was added to the scintillation vial. Concentrations
of 14CO2 from each blood sample were quantified
using a Beckman-Coulter 1900 TA LC counter.
Hindlimb glucose utilization rate was calculated as
the difference between arterial and venous samples
normalized to femoral blood flow rate and hindlimb
weight. Glucose oxidation rates were determined
from the difference between venous and arterial 14C
specific activities normalized to femoral blood flow
rate and hindlimb weight. Millimoles of glucose oxidized were calculated from blood 14C using the specific activity of the infused radiolabeled glucose.
Primary Muscle Glucose Metabolism
Skeletal muscle glucose uptake and oxidation
was determined in control (n = 8) and MI-IUGR
(n = 6) fetuses as previously described (Cadaret
et al., 2017b). Briefly, fetal soleus muscle was
dissected longitudinally into ~500-mg strips and
incubated in Krebs–Henseleit bicarbonate buffer
(KHB) containing no additive (basal), insulin (5
mU/mL Humulin-R), or tumor necrosis factor
alpha (TNFα) (20 ng/mL; Sigma-Aldrich). For
glucose uptake studies, muscle was incubated in
treatment-spiked KHB media containing 1 mM
[3H]2-deoxyglucose for 20 min. For glucose oxidation studies, muscle strips were incubated in
treatment-spiked KHB media containing [14C-U]
D-glucose for 2 h, and 14CO2. was captured for 2 h.
Statistical Analysis
All data were analyzed using the Mixed procedure in SAS (SAS Institute, Cary NC) with
fetus as the experimental unit. Variables in
GSIS, HEC, and ex vivo studies were analyzed
for effects due to treatment, period (or incubation condition), and interaction, with period/
condition as a repeated variable. For GSIS and
HEC studies, samples within each period were
averaged for each fetus. Likewise, three technical replications/condition were averaged for
each fetus in ex vivo studies. Fetal weights and
dGA 123 CBC data were analyzed for effects
due to treatment. Data are presented as means
± SEM.
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RESULTS

Fetal Insulin Secretion

Fetal Weights and CBC
Fetal weights at necropsy were ~22% less
(P < 0.05) for MI-IUGR fetuses than for controls.
At ~123 dGA, circulating WBC, lymphocytes,
monocytes, and granulocytes were increased
(P < 0.05) in dams treated with LPS compared
to those given saline. However, circulating WBC,
lymphocytes, and monocytes were decreased
(P < 0.05) in MI-IUGR fetuses compared to
controls. Circulating granulocytes were similar in
all fetuses.

Figure 1. Plasma insulin (A) and glucose (B) concentrations at
basal and hyperglycemic states in control (n = 6) and IUGR (n = 5)
fetuses during GSIS.

During square-wave hyperglycemic clamps, glucose was increased (P < 0.05) to similar concentrations in all fetuses by design. At baseline, however,

Figure 2. In vivo hindlimb specific glucose uptake (A), glucose
oxidation (B), and lactate secretion (C) determined under basal and
hyperinsulinemic clamp conditions in control (n = 4) and IUGR
(n = 4) fetuses. a,b,cMeans with differing superscripts differ (P < 0.05).
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Table 1. Fetal blood analysis during HEC study
Control
n
Plasma insulin, ng/mL
Arterial pH
Arterial pCO2, mmHg
Arterial HCO3, mM

Basal
4
0.37 ± 1.9
7.38 ± 0.02
52.9 ± 1.7
30.3 ± 0.5

HEC
4
0.64 ± 1.2
7.35 ± 0.01
52 ± 0.5
28.6 ± 0.2

MI-IUGR
Basal
4
15.63 ± 1.9
7.33 ± 0.02
57 ± 1.7
29.4 ± 0.5

HEC
4
14.39 ± 1.2
7.334 ± 0.01
53.7 ± 0.5
27.9 ± 0.3

P value
Treatment

Period

T*P

NS
NS
NS
<0.001

<0.001
0.05
0.06
NS

NS
NS
NS
NS

Values are expressed as means ± SE.

plasma glucose concentrations were less (P < 0.05) in
MI-IUGR fetuses compared to controls (Figure 1).
In response to hyperglycemia, plasma insulin concentrations increased (P < 0.05) from baseline in all
fetuses, but concentrations at baseline and hyperglycemia were substantially less (P < 0.05) in MI-IUGR
fetuses compared to controls.
Fetal Hindlimb Glucose Utilization
Baseline hindlimb glucose uptake and oxidation rates were similar between MI-IUGR and
control fetuses (Figure 2). As plasma insulin was
experimentally increased (P < 0.05) between baseline and HEC conditions, hindlimb glucose uptake
likewise increased (P < 0.05) to similar rates in all
fetuses. Hindlimb glucose oxidation was increased
(P < 0.05) by HEC in all fetuses, but the change
was substantially less (P < 0.05) in MI-IUGR fetus
compared to controls. There were no differences between treatments or periods for hindlimb lactate secretion (Table 1). In response to HEC, arterial pH
was increased (P < 0.05) and arterial CO2 tended to
be increased (P < 0.10) in all fetuses. Arterial HCO3
content was reduced (P < 0.05) in MI-IUGR fetuses
compared to controls regardless of condition.
Ex Vivo Skeletal Muscle Metabolism
Glucose uptake in primary soleus muscle was
similar in all fetuses at each condition (Figure 3).
Glucose oxidation rates were similar in all fetuses
under basal conditions, but insulin- and TNFαstimulated glucose oxidation rates were decreased
(P < 0.05) in soleus muscle from MI-IUGR fetuses.
DISCUSSION

Figure 3. Ex vivo skeletal muscle glucose uptake (A) and oxidation
(B) under basal, insulin, and TNFα-stimulated conditions measured
in control (n = 8) and IUGR (n = 6) fetuses. a,b,cMeans with differing
superscripts differ (P < 0.05).

In the present study, chronic maternal inflammation yielded IUGR and muscle-centric adaptations
that shift glucose metabolism. Our MI-IUGR fetuses
oxidized substantially smaller amounts of glucose
within hindlimb tissues with no change in hindlimb
glucose uptake. This was due to poor responsiveness

to metabolic stimulators, as basal glucose oxidation
in primary muscle strips from MI-IUGR fetuses was
normal but insulin- and TNFα-stimulated glucose
oxidation were decreased. Additionally, MI-IUGR
fetuses exhibited poor β cell function that was related to
reduced islet responsiveness to glucose. These findings
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indicate that chronic maternal inflammation restricts
fetal growth and produces a metabolic phenotype that
mirrors other IUGR models. Thus, inflammation is
likely a key part of the adaptive fetal programming
that increases the risk for metabolic dysfunction in
IUGR-born offspring. We attribute reduced muscle
glucose oxidation to a shift toward anaerobic glycolysis (Brown et al., 2015), which produces lactate
that can be utilized by crucial organs such as the brain
and heart (Yates et al., 2012a). Although circulating
lactate was not different in the present study, it is likely
that lactate was being cleared by the MI-IUGR liver
for gluconeogenesis (Limesand et al., 2007). Impaired
β cell function at hyperglycemia but not resting conditions indicates that the disruption is in stimulus-secretion coupling (i.e., the ability of β cells to respond to
rising glucose). Previous studies show that other stress
factors act similarly (Yates et al., 2012b; Chen et al.,
2014). Leukocytes are potent cytokine producers, and
reduced circulating WBC counts in MI-IUGR fetuses
despite greater counts in ewes indicates a compensatory action by the fetus to moderate the heightened
inflammatory environment. Although circulating
cytokine concentrations were not determined in these
fetuses, we previously observed increased plasma
TNFα in rat fetuses well after maternal inflammation
has subsided (Cadaret et al., 2017a).
IMPLICATIONS
Chronic maternofetal inflammation resulted
in IUGR fetuses with altered muscle metabolic
capacity and reduced β cell function. This phenotype is characteristic of low birth weight humans
and livestock, and thus our findings indicate that
fetal adaptations to chronic inflammation are a
major factor in the development of low birthweight
pathologies. Furthermore, muscle-centric adaptive
fetal programming of inflammatory regulation may
be a target for interventions to improve outcomes
in low birthweight offspring.
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